Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to further characterize the efficacy, safety, and tolerability
of a single fixed dose level of vilazodone compared to placebo in patients with major
depressive disorder.